公司资料
LadRx 股价、新闻与催化剂
- 股票代码:
- LADX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.01 USD (0.00%)
收盘价
最后更新: 2026年6月22日
—
市值
股价为何变动
Current closing-price context is not available for LADX.
公司概览
业务概览
LadRx was a biotechnology company historically focused on oncology and drug delivery before becoming a legacy ticker. Its story centered on the challenge of turning a narrow therapeutic concept into durable value.
所在地与行业分类
LadRx was headquartered in the United States and traded on NASDAQ. It sat in small-cap oncology and drug-delivery biotechnology.
商业模式特征
The company depended on clinical progress, strategic changes, and capital support while advancing a narrow pipeline. Investors historically watched proof-of-concept and financing runway.
生物医药行业定位
LadRx is best understood as a historical small-cap oncology biotech name. Like many micro-cap drug developers, its stock was driven by pipeline risk and capital needs.
未来催化剂
- LadRx is now a legacy / closeout story, so the catalysts are any residual strategic or asset-resolution update. The market is focused on what value remains.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。